Quoin Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	1	5	7	15	8	5	13	38	17
Market Cap Growth	-	-29.64%	-54.71%	79.96%	69.77%	-60.57%	-66.50%	125.55%	-
Enterprise Value	-2	-6	-6	8	9	-0	7	29	7
PE Ratio	-0.56	-0.56	-0.73	-0.71	-4.03	-3.19	-2.03	-4.32	-3.53
PB Ratio	0.46	0.86	0.93	23.13	-1.28	1.09	2.94	6.47	1.90
P/FCF Ratio	-0.62	-0.62	-0.79	-2.40	-5.77	-3.83	-1.68	-6.76	-3.47
P/OCF Ratio	-0.62	-0.62	-0.81	-2.66	-6.31	-3.83	-1.73	-6.87	-3.75
EV/EBITDA Ratio	0.68	0.68	0.70	-0.39	-4.80	0.18	-1.17	-3.93	-1.55
EV/EBIT Ratio	0.67	0.67	0.69	-0.38	-4.56	0.18	-1.15	-3.87	-1.51
EV/FCF Ratio	0.74	0.74	0.68	-1.22	-6.38	0.22	-0.95	-5.23	-1.49
Debt / Equity Ratio	-	-	-	-	-0.18	0.07	-	-	-
Debt / EBITDA Ratio	-	-	-	-	-0.62	-0.22	-	-	-
Debt / FCF Ratio	-	-	-	-	-0.83	-0.25	-	-	-
Quick Ratio	2.99	2.99	3.64	1.64	0.04	5.14	3.80	6.97	9.30
Current Ratio	3.15	3.15	3.79	1.79	0.06	5.11	3.80	6.97	9.30
Interest Coverage	-	-	-12.14	-14.72	-43.56	-	-1004.62	-6.25	-463.16
Return on Equity (ROE)	-105.10%	-105.10%	-296.00%	721.40%	-64.60%	-26.20%	-101.10%	-156.40%	-78.60%
Return on Assets (ROA)	-55.70%	-55.70%	-89.20%	-399.90%	-32.20%	-17.30%	-68.80%	-94.50%	-64.80%
Return on Capital (ROIC)	-165.58%	-165.58%	-124.99%	-922.76%	30.96%	-31.78%	-210.06%	-129.60%	-55.97%
Earnings Yield	-1238.95%	-179.39%	-136.32%	-141.23%	-24.81%	-31.37%	-49.21%	-23.13%	-28.32%
FCF Yield	-299.47%	-162.41%	-126.86%	-41.75%	-17.33%	-26.11%	-59.43%	-14.78%	-28.81%
Buyback Yield / Dilution	-144.43%	-144.43%	98.47%	-31.42%	-	-928242.65%	-15.59%	-22.84%	-22.40%
Total Shareholder Return	-144.43%	-144.43%	98.47%	-31.42%	-	-928242.65%	-15.59%	-22.84%	-22.40%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).